Avai Bio Stock

Avai Bio FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Avai Bio (AVAI) as of Aug 4, 2026 is 101.62 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 69.13 % — a change of 47.01% (higher).

FCF Conversion

101.62 %

YoY

47.01%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Avai Bio is 2026 101.62 % . FCF Conversion Rate (FCF/EBITDA) of Avai Bio was 2025 69.13 % . It decreases by 47.01% higher compared to the previous year.
Access this data via the Eulerpool API

Avai Bio Stock analysis

What does Avai Bio do? Trend Innovations Holding Inc is a multi-awarded developer and manufacturer of innovative products and technologies with locations in the USA and Europe. The privately held company offers its services in various sectors, including aviation, defense, medicine, energy, industrial automation, and advanced electronics. The company was founded in 2000 and has since continuously evolved. Over the years, it started as a supplier to the aerospace industry and then became active in various fields such as medicine, energy, and industrial automation. Trend Innovations has established itself as an innovative developer and manufacturer of advanced technologies and products, gaining a reputation as a trusted partner that is always up-to-date with the latest technology. The mission of Trend Innovations is to provide tailored solutions to customers worldwide based on their specific needs and requirements. The company offers a wide range of services, including engineering and design, prototyping, manufacturing and assembly, as well as consulting and support. The company places great importance on quality, reliability, and quick responsiveness. In the aviation sector, Trend Innovations is a leading provider of aviation solutions used in both civil and military aviation. The offerings include flight control and navigation systems, structure and component developments, wireless communication solutions, and aircraft cabin systems. In the defense sector, Trend Innovations offers highly specialized technologies and products designed for military use and security agencies. These include camouflage solutions, weapon systems, communication and reconnaissance systems, as well as protection systems. In the medical field, Trend Innovations develops and manufactures medical products that contribute to improving the quality of life for patients. The offerings include medical devices for diagnosis and therapy, implants and prostheses, as well as medical instruments and consumables. In the energy industry, Trend Innovations develops innovative products and solutions that help reduce energy consumption and promote the use of renewable energies. The offerings include energy management and control solutions, solar-powered devices and components, as well as energy-saving and efficiency systems. In the industrial automation sector, Trend Innovations offers solutions for automating production processes. The offerings include robotics systems, collaborative robotics, autonomous transport systems, and automation solutions for manufacturing, storage, and logistics. Trend Innovations offers a wide range of products, including flight control and navigation systems, in-flight entertainment solutions for civil and military aviation, medical devices, implants and prostheses, automated production and transport systems, as well as sustainable energy solutions. All products from Trend Innovations are tailored to the specific needs of customers and manufactured according to the highest quality standards. In conclusion, Trend Innovations Holding Inc is an innovative developer and manufacturer of technologies and products in various sectors such as aviation, defense, medicine, energy, and industrial automation. With a wide range of services and products tailored to the specific needs of customers, Trend Innovations has established itself as a reliable partner in the market. The company has an impressive history and, thanks to its expertise and innovation, remains at the forefront of technology. Avai Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Avai Bio stock

FCF Conversion Rate (FCF/EBITDA) of Avai Bio is 101.62 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Avai Bio changed from 69.13 % to 101.62 %, representing a 47.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Avai Bio since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Avai Bio with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Avai Bio

All Key Metrics — Avai Bio